A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Clinical trial NCT02156375 · COMPLETED
Trial details
- NCT number
- NCT02156375
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2014-12-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.